Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
19.77
-0.17 (-0.85%)
At close: Mar 28, 2025, 4:00 PM
19.47
-0.30 (-1.51%)
After-hours: Mar 28, 2025, 7:00 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.13 billion as of March 28, 2025. Its market cap has decreased by -28.23% in one year.
Market Cap
1.13B
Enterprise Value
254.01M
1-Year Change
-28.23%
Ranking
Category
Stock Price
$19.77
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.13B, an increase of 106.56%. That is a compound annual growth rate of 40.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.13B | -27.00% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |